Publicaciones (69) Publicaciones de GUSTAVO PURAS OCHOA

2024

  1. Carbon-Based Nanostructures as Emerging Materials for Gene Delivery Applications

    Pharmaceutics, Vol. 16, Núm. 2

  2. Expanding the horizon of transient CAR T therapeutics using virus-free technology

    Biotechnology Advances, Vol. 72

2023

  1. An SPM-Enriched Marine Oil Supplement Shifted Microglia Polarization toward M2, Ameliorating Retinal Degeneration in rd10 Mice

    Antioxidants, Vol. 12, Núm. 1

  2. Assessment of Different Niosome Formulations for Optogenetic Applications: Morphological and Electrophysiological Effects

    Pharmaceutics, Vol. 15, Núm. 7

  3. Bektore ez-biral lipidikoak garatzeko erabiltzen diren teknikak eta hauen garrantzia etorkizunerako

    Osasun zientziak: V. Ikergazte Nazioarteko Ikerteta Euskaraz. 2023eko maitzaren 17, 18 eta 19 Donostia, Euskal Herria.

  4. Erratum: Nanodiamonds Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases (ACS Appl. Mater. Interfaces (2022) 14:11 (13665−13677) DOI: 10.1021/acsami.2c02182)

    ACS Applied Materials and Interfaces

  5. Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior

    Biomolecules, Vol. 13, Núm. 11

  6. Long-term biophysical stability of nanodiamonds combined with lipid nanocarriers for non-viral gene delivery to the retina

    International Journal of Pharmaceutics, Vol. 639

  7. Stability of polymeric cationic niosomes and their plasmid DNA-based complexes as gene delivery carriers

    Drug Delivery, Vol. 30, Núm. 1

  8. Stem Cell-Derived Extracellular Vesicles as a Potential Therapeutic Tool for Eye Diseases: From Benchtop to Bedside

    Advances in experimental medicine and biology, Vol. 1410, pp. 127-143

  9. The role of microfluidics and 3D-bioprinting in the future of exosome therapy

    Trends in Biotechnology, Vol. 41, Núm. 11, pp. 1343-1359

2022

  1. Design of double functionalized carbon nanotube for amphotericin B and genetic material delivery

    Scientific Reports, Vol. 12, Núm. 1

  2. Nanodiamond Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases

    ACS Applied Materials and Interfaces, Vol. 14, Núm. 11, pp. 13665-13677

  3. Therapeutic Opportunities and Delivery Strategies for Brain Revascularization in Stroke, Neurodegeneration, and Aging

    Pharmacological reviews, Vol. 74, Núm. 2, pp. 439-461

2021

  1. Applying 3D constructs for gene therapy

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 93-95

  2. Correlation between biophysical properties of niosomes elaborated with chloroquine and different tensioactives and their transfection efficiency

    Pharmaceutics, Vol. 13, Núm. 11

  3. Current insights into 3D bioprinting: An advanced approach for eye tissue regeneration

    Pharmaceutics, Vol. 13, Núm. 3, pp. 1-28

  4. Design and validation of a process based on cationic niosomes for gene delivery into novel urine-derived mesenchymal stem cells

    Pharmaceutics, Vol. 13, Núm. 5

  5. How far are non‐viral vectors to come of age and reach clinical translation in gene therapy?

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

  6. Mesenchymal stem cells as a gene delivery tool: Promise, problems, and prospects

    Pharmaceutics, Vol. 13, Núm. 6